secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theriva Biologics, Inc. (TOVX)
CIK:        0000894158
Form:       8-K
Filed at:   2024-08-26T23:59:59+00:00
Accession:  0001104659-24-092644
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Theriva Biologics effects 1-for-25 reverse stock split to meet NYSE American price rules
--------------------------------------------------------------------------------

- Reverse split ratio of 1-for-25; shares reduced from 25,131,230 to approximately 1,005,249.
- Effective 12:01 a.m. ET on August 26, 2024; trading began on post-split basis same day.
- No fractional shares issued; holders otherwise entitled to fractional shares receive rounding up to next whole share.
- Exercise price and share count under options, warrants, and equity plans adjusted proportionately.
- Trading symbol unchanged ('TOVX'); new CUSIP number is 87164U508.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/894158/000110465924092644/0001104659-24-092644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/894158/000110465924092644/tm2422579d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-092644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer